As at 6:38 PM on 22/5/2013
The Share Price is: 57.00 GBX
Home > News
As you’d expect from a company in emerging technologies and world class IP, our companies generate considerable news. Full details of all RNS and portfolio company related announcements are detailed below:
INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 JANUARY 2013
16 Apr 2013
Result of General Meeting
11 Apr 2013
New Fusion portfolio company – PH Therapeutics Ltd
10 Apr 2013
Placing to raise £20 million, new university agreements and Notice of General Meeting
25 Mar 2013
Appointment of Nominated Adviser and Broker
25 Feb 2013
Phase Focus, signs licensing agreement with Gatan, the world’s leading manufacturer of instrumentation for electron microscopes
19 Feb 2013
New ScanTrainer Transabdominal ultrasound simulator announced at IMSH in Orlando, Florida
06 Feb 2013
Fusion directors join board of Welsh £100 million investment fund, Arthurian
05 Feb 2013
Asalus successfully completes UltravisionTM ‘first-in-man’ clinical trial.
24 Jan 2013
Asalus, recruits new Chairman and raises a further £1.25m to take product to market
22 Jan 2013